  |
3ERD |
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
 |
  |
3DCT |
FXR with SRC1 and GW4064 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
3D24 |
Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
3CWD |
Molecular recognition of nitro-fatty acids by PPAR gamma |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
3CS8 |
Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
3BXL |
Crystal structure of the R-type calcium channeL (CaV2.3) IQ domain and CA2+calmodulin complex |
B |
A |
EF Hand-like |
|
  |
3BUA |
Crystal Structure of TRF2 TRFH domain and APOLLO peptide complex |
F |
B |
Telomeric repeat binding factor (TRF) dimerisation domain |
|
  |
3BU8 |
Crystal Structure of TRF2 TRFH domain and TIN2 peptide complex |
D |
B |
Telomeric repeat binding factor (TRF) dimerisation domain |
|
  |
3BQO |
Crystal Structure of TRF1 TRFH domain and TIN2 peptide complex |
B |
A |
Telomeric repeat binding factor (TRF) dimerisation domain |
|
  |
3BQD |
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
3BEJ |
Structure of human FXR in complex with MFA-1 and co-activator peptide |
E |
A |
Nuclear receptor ligand-binding domain |
|
  |
2ZMH |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2ZMI |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2ZMJ |
Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2ZLC |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2ZLA |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2ZL9 |
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2VAY |
CALMODULIN COMPLEXED WITH CAV1.1 IQ PEPTIDE |
B |
A |
EF Hand-like |
|
  |
2R28 |
The complex Structure of Calmodulin Bound to a Calcineurin Peptide |
C |
AB |
EF Hand-like |
|
  |
2R7G |
Structure of the retinoblastoma protein pocket domain in complex with adenovirus E1A CR1 domain |
E |
A |
Cyclin-like |
|
  |
2QPY |
AR LBD with small molecule |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2Q7J |
The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and a TIF2 box 3 Coactivator Peptide 740-753 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2Q7I |
The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2P54 |
a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2P1V |
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2\'-propoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2P1T |
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2\'-methoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2P1U |
Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2\'-ethoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2OVH |
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2OBH |
Centrin-XPC peptide |
C |
DA |
EF Hand-like |
|
  |
2O60 |
Calmodulin bound to peptide from neuronal nitric oxide synthase |
B |
A |
EF Hand-like |
|
  |
2O4R |
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2O4J |
Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and the NR2 Box of DRIP 205 |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2O5G |
Calmodulin-smooth muscle light chain kinase peptide complex |
B |
A |
EF Hand-like |
|
  |
2O02 |
Phosphorylation independent interactions between 14-3-3 and Exoenzyme S: from structure to pathogenesis |
P |
A |
alpha-alpha superhelix |
|
  |
2NV7 |
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2J7Y |
STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2J7X |
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2HWN |
Crystal Structure of RII alpha Dimerization/Docking domain of PKA bound to the D-AKAP2 peptide |
E |
AB |
Dimerization-anchoring domain of cAMP-dependent PK regulatory subunit |
|
  |
2HQW |
Crystal Structure of Ca2+/Calmodulin bound to NMDA Receptor NR1C1 peptide |
B |
A |
EF Hand-like |
|
  |
2HFP |
Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2H6H |
Y365F Protein Farnesyltransferase Mutant Complexed with a Farnesylated DDPTASACVLS Peptide Product at 1.8A |
P |
AB |
alpha-alpha superhelix |
|
  |
2GTK |
Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2GPO |
Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 |
C |
A |
Nuclear receptor ligand-binding domain |
|
  |
2GNS |
Design of specific peptide inhibitors of phospholipase A2: Crystal structure of the complex formed between a group II phospholipase A2 and a designed pentapeptide Ala- Leu- Val- Tyr- Lys at 2.3 A resolution |
P |
A |
Phospholipase A2. PLA2 |
|
  |
2GGM |
Human centrin 2 xeroderma pigmentosum group C protein complex |
C |
ABD |
EF Hand-like |
|
  |
2FVJ |
A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro |
B |
A |
Nuclear receptor ligand-binding domain |
|
  |
2FOT |
Crystal structure of the complex between calmodulin and alphaII-spectrin |
C |
A |
EF Hand-like |
|
  |
2F3Z |
Calmodulin/IQ-AA domain complex |
B |
A |
EF Hand-like |
|
  |
2F3Y |
Calmodulin/IQ domain complex |
B |
A |
EF Hand-like |
|
  |
2CCH |
THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE |
E |
B |
Cyclin-like |
|
